Akihiro Noda
Itabashi, 1738610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Investigating the fate of Zirconium-89 labelled antibody in cynomolgus macaques.
Journal: Nuclear medicine and biology
Published: November 03, 2024
Pediatric Acute Paradoxical Cerebral Embolism with Pulmonary Embolism Caused by Extremely Small Patent Foramen Ovale.
Journal: Open medicine (Warsaw, Poland)
Published: July 24, 2018
Delayed increase in serum acetaminophen concentration after ingestion of a combination medications: a case report.
Journal: The Journal of international medical research
Published: June 09, 2018
Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155.
Journal: Nuclear medicine and biology
Published: September 29, 2017
Design and Synthesis of an Easily Obtainable Maleimide Reagent N-[2-(4-[18F]fluoro-N-methylbenzenesulfonamido)ethyl]maleimide ([18F]FBSEM) to Radiolabel Thiols in Proteins.
Journal: Bioconjugate chemistry
Published: December 13, 2016
Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys.
Journal: Molecular imaging and biology
Published: April 29, 2016
Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.
Journal: Anticancer research
Published: November 14, 2013
Chronic eosinophilic pneumonia presenting with acute onset.
Journal: Asian Pacific journal of allergy and immunology
Published: February 12, 2013
Sepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 13, 2012
Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model.
Journal: Nuclear medicine and biology
Published: May 30, 2012
Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques.
Journal: Nuclear medicine and biology
Published: May 11, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026